IRIS - Res&Arch Institutional Research Information System - Research & Archive

LISO, Arcangelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.324
AS - Asia 1.985
EU - Europa 1.896
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 60
OC - Oceania 1
Totale 7.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.157
SG - Singapore 949
IT - Italia 359
IE - Irlanda 299
UA - Ucraina 283
BR - Brasile 274
RU - Federazione Russa 256
CN - Cina 247
HK - Hong Kong 216
SE - Svezia 186
VN - Vietnam 183
DE - Germania 129
FR - Francia 103
FI - Finlandia 96
KR - Corea 85
BD - Bangladesh 82
CA - Canada 71
GB - Regno Unito 68
IN - India 47
AR - Argentina 32
TR - Turchia 28
IQ - Iraq 25
CH - Svizzera 20
MX - Messico 20
ZA - Sudafrica 18
CR - Costa Rica 17
UZ - Uzbekistan 17
PL - Polonia 16
NL - Olanda 15
AT - Austria 14
GT - Guatemala 14
SA - Arabia Saudita 14
BE - Belgio 13
MA - Marocco 13
PK - Pakistan 13
CO - Colombia 11
EC - Ecuador 11
ID - Indonesia 11
PH - Filippine 11
SV - El Salvador 10
VE - Venezuela 10
ES - Italia 9
CW - ???statistics.table.value.countryCode.CW??? 7
EE - Estonia 7
EU - Europa 7
PY - Paraguay 7
GP - Guadalupe 6
HN - Honduras 6
JP - Giappone 6
LB - Libano 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
CZ - Repubblica Ceca 5
GR - Grecia 5
JO - Giordania 5
CL - Cile 4
EG - Egitto 4
IL - Israele 4
NI - Nicaragua 4
NP - Nepal 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SC - Seychelles 4
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
LT - Lituania 3
OM - Oman 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
MY - Malesia 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
AU - Australia 1
BB - Barbados 1
CY - Cipro 1
HU - Ungheria 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
NE - Niger 1
NG - Nigeria 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 7.633
Salva come PNG Salva come JPEG
Città #
Singapore 642
San Jose 361
Chandler 311
Dublin 298
Ashburn 266
Hong Kong 214
San Mateo 176
Jacksonville 147
Council Bluffs 146
Santa Clara 135
Perugia 113
Moscow 91
Boardman 89
Beijing 85
Seoul 84
Dong Ket 80
Princeton 80
Medford 69
Ann Arbor 65
Lauterbourg 64
Wilmington 59
Altamura 54
New York 52
Andover 46
Los Angeles 46
Lawrence 42
Dallas 33
Piscataway 32
Ho Chi Minh City 30
Helsinki 27
Munich 24
Hanoi 21
North Bergen 21
São Paulo 21
Des Moines 20
Phoenix 20
Frankfurt am Main 16
Milan 16
Montreal 16
Rome 16
Houston 15
Izmir 14
Woodbridge 14
Brooklyn 13
Brussels 13
Charlotte 13
London 13
Abbeville 12
Falls Church 12
Guatemala City 12
Saint Petersburg 12
San José 12
Norwalk 11
The Dalles 11
Toronto 11
Belo Horizonte 10
Denver 10
Johannesburg 10
Orem 10
San Paolo di Civitate 10
Shanghai 10
Manchester 9
San Salvador 9
Tashkent 9
Turku 9
Haiphong 8
Riverbank 8
San Francisco 8
Amsterdam 7
Atlanta 7
Baghdad 7
Buffalo 7
Chennai 7
Columbus 7
Curitiba 7
Da Nang 7
Fairfield 7
Falkenstein 7
Florence 7
Naples 7
Willemstad 7
Bologna 6
Coccaglio 6
Mexico City 6
Newark 6
Philadelphia 6
Rio de Janeiro 6
Riyadh 6
Turin 6
Asunción 5
Auburn Hills 5
Buenos Aires 5
Guangzhou 5
Guayaquil 5
Las Vegas 5
Porto Alegre 5
Stockholm 5
Tokyo 5
Tunis 5
Uberlândia 5
Totale 4.630
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 179
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 174
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 172
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 152
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 149
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 137
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 137
WESTERN BLOT IDENTIFICATION OF NPM1 LEUKEMIC MUTANTS IN CYTOLOGICAL AML SAMPLES: A POWERFUL DIAGNOSTIC TECHNIQUE 135
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 127
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 127
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 123
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 122
Aberrant hypermutation of PIM1, PAX5, RhoH/TTF and cMYC in nodular lymphocyte predominance Hodgkin's disease 121
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 121
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. 118
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 117
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 117
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 117
BRAF mutations in hairy-cell leukemia. 116
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 113
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 113
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 108
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 107
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin 107
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. 106
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 105
Targeted antibodies in the treatment of lymphomas. 105
CYTOPLASMIC MUTATED NUCLEOPHOSMIN DEFINES THE MOLECULAR STATUS OF A SIGNIFICANT FRACTION OF MYELOID SARCOMAS 105
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice 105
Evolving concepts in the pathogenesis of hairy-cell leukaemia. 104
Absence of nucleophosmin leukemic mutants in B and T cells from AML with NPM1 mutations: Implications for the cell of origin of NPMC plus AML 95
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6 94
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 93
Linking surgical specimen length and examined lymph nodes in colorectal cancer patients 92
Seasonality of birth for skin melanoma deserves further investigation 91
Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules. 90
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. 90
The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative Stress 89
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors 89
PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia 88
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). 87
Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines 86
High anti-PLAC1 antibody levels in idiopathic infertile patients with repeated unexplained implantation failure 85
Seasonal Variation in Skin Cancer Diagnosis 85
PLAC1 immunization does not induce infertility in mice 83
Vaccine therapy of B cell malignancies: Different strategies for a novel approach 81
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML). 80
Dissecting the Hierarchical Level of Hematopoietic Progenitors' Involvement in AML with NPM1 Gene Mutation and Their Engraftment Potential in Immunocompromised Mice. 79
Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma. 79
Minimally invasive surgical versus transcatheter aortic valve replacement: A multicenter study 78
From fever to immunity: A new role for IGFBP-6? 78
Selective silencing of the NPM1 mutant protein and apoptosis induction upon ATRA in vitro treatment of AML cells carrying NPM1 mutations. 77
Modulatory effects of mycobacterial heat-shock protein 70 in DNA vaccination against lymphoma 76
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints. 76
SELECTIVE SILENCING OF THE NPM1 MUTANT PROTEIN AND APOPTOSIS INDUCTION UPON ATRA IN VITRO TREATMENT OF AML CELLS CARRYING NPM1 MUTATIONS 76
CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance. 74
Persistent immune stimulation exacerbates genetically driven myeloproliferative disorders via stromal remodeling 74
Droplets generated from toilets during urination as a possible vehicle of carbapenem-resistant Klebsiella pneumoniae 72
In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML. 71
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. 70
Seasonal variation in the month of birth in patients with skin cancer 70
IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis 66
Computational modeling of the immune response to tumor antigens. 66
Insulin-like growth factor binding protein 6 in rheumatoid arthritis: A possible novel chemotactic factor? 64
EVIDENCE FOR CD34+HEMATOPOIETIC PROGENITOR CELL INVOLVEMENT IN ACUTE MYELOID LEUKEMIA WITH NPM1 GENE MUTATION: IMPLICATIONS FOR THE CELL OF ORIGIN 63
Immunophenotypic and molecular features of ‘cuplike’ acute myeloid leukemias 63
null 62
Western blot identification of NPM1 leukemic mutants in cytological AML samples: A powerful diagnostic technique 62
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 60
CD34-POSITIVE HEMATOPOIETIC PROGENITOR CELLS ARE INVOLVED IN ACUTE MYELOID LEUKEMIA WITH NPM1 GENE MUTATION 55
Tumor Protein D52 (TPD52): A Novel B Cell/Plasma Cell Molecule Identified through a Proteomic Approach and Characterized by Unique Expression Pattern and Ca2+-Dependent Association with Annexin VI 55
Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes 54
Multidrug-Resistant Bacteria Contaminating Plumbing Components and Sanitary Installations of Hospital Restrooms 53
Proteasome inhibitors as a possible therapy for SARS-CoV-2 52
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 49
IGFBP-6 Network in Chronic Inflammatory Airway Diseases and Lung Tumor Progression 48
Evidence for CD34+Hematopoietic Progenitor Cell Involvement in Acute Myeloid Leukemia with NPM1 Gene Mutation: Implications for the Cell of Origin 47
Redox Biology and Insulin-like Growth Factor-Binding Protein-6: A Potential Relationship 46
Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells 45
Insulin Growth Factor Binding Protein-6 and the Liver 42
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study 36
Activity of a foam in preventing rebound of vancomycin-resistant Enterococcus faecium-containing droplets generated from the toilet bowl 35
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 29
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia 29
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL) 28
Donor selection for allogenic hemopoietic stem cell transplantation: Clinical and ethical considerations 26
High anti PLAC 1 antibody levels in idiopathic infertile patients with repetaed unexplained implantation failure 25
Preliminary evidence for high anti-PLAC1 antibody levels in infertile patients with repeated unexplained implantation failure 24
Reduced percentage of natural killer cells associated with impaired cytokine network in the secretory endometrium of infertile PCOS women 23
Hematopoietic Stem Cell Transplantation: A Bioethical Lens 22
USE OF ANTI-PLAC1 PROTEIN ANTIBODIES AS BIOMARKERS OF INFERTILITY, DIAGNOSTIC KIT FOR THE DETECTION OF THE IMMUNE RESPONSE AGAINST PLAC1 AND USE OF PLAC1 PROTEIN IN THERAPEUTIC AND CONTRACEPTIVE FIELDS 21
Cohesin complex is a major player on the stage of leukemogenesis 19
DONOR SELECTION FOR ALLOGENIC HAEMOPOIETIC STEM CELL TRANSPLANTATION: CLINICAL AND ETHICAL CONSIDERATIONS 18
Genome-wide computational approach for the prediction of duplications generating protein localization signals 18
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 18
Reduced percentage of postovulatory natural killer cells associated with impaired cytokines network in the secretory endometrium of infertile PCOS women 18
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi 18
Use of design of experiments to optimize the production of microbial probiotic biofilms 18
IGFBP-6 as a potential therapeutic target in musculoskeletal disorders 17
Low dose intravenous bevacizumab for thetreatment of anaemia in hereditary haemorrhagic telangiectasia 16
Totale 7.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.473
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022371 0 0 0 0 22 3 4 196 6 9 57 74
2022/2023989 71 177 10 76 72 100 0 46 384 9 32 12
2023/2024333 29 37 25 7 4 2 80 9 29 7 49 55
2024/20251.054 30 81 99 26 135 45 36 80 210 68 153 91
2025/20262.658 175 137 115 232 307 217 379 238 345 299 112 102
2026/20271.047 63 106 199 603 76 0 0 0 0 0 0 0
Totale 7.842